Treatment with 17β estradiol significantly inhibited the malignant behavior of HCC cells through E2/ERβ/MAPK pathway-mediated upregulation of the NLRP3 inflammasome [136]. This evidence concerns the gene ESR2 and hepatocellular carcinoma.